PREDICTIVE UTILITY OF MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) AND D-DIMER IN RISK STR ATIFICATION OF SEPSIS: A PROSPECTIVE COHORT STUDY



Cite item

Full Text

Abstract

Background: Sepsis is a severe and life-threatening clinical syndrome characterized by a dysregulated host immune response to infection. This maladaptive response promotes widespread endothelial injury and abnormalities in coagulation, often progressing to multi-organ dysfunction and death. Mortality rates remain high, highlighting the urgent need for reliable biomarkers to enable early identification of patients at high risk. Such tools are particularly valuable in low- and middle-income countries (LMICs), where access to advanced diagnostic and therapeutic resources is limited. Monocyte Chemoattractant Protein-1 (MCP-1) is a chemokine that reflects hyperactivation of the innate immune system, while D-dimer indicates activation of coagulation and fibrinolysis. Although both pathways are central to the pathophysiology of sepsis, data evaluating their combined prognostic value in LMIC settings remain scarce.

Objectives: This study aimed to assess the prognostic significance of MCP-1 and D-dimer, both individually and in combination, for predicting 28-day mortality in patients with sepsis.

Methods: We conducted a prospective cohort study involving 83 adult patients with newly diagnosed sepsis at Dr. Saiful Anwar General Hospital, Malang, Indonesia. Serum MCP-1 levels were measured using enzyme-linked immunosorbent assay (ELISA), and plasma D-dimer levels were determined by immunoturbidimetry at the time of diagnosis. Patients were followed for 28 days, and survival outcomes were evaluated using Kaplan–Meier survival analysis and Cox proportional hazards regression models.

Results: Among the 83 participants, 58 patients (70%) died within 28 days. Non-survivors demonstrated significantly higher MCP-1 and D-dimer levels compared with survivors. An MCP-1 concentration ≥123.03 pg/mL was strongly associated with increased mortality (HR 2.664, p = 0.005). Elevated D-dimer (≥43.5 mg/L FEU) showed a weaker individual association, but when combined with MCP-1, predictive accuracy for mortality was significantly enhanced (HR 3.986, p = 0.037).

Conclusion: The concurrent elevation of MCP-1 and D-dimer identifies patients with sepsis who are at markedly increased risk of death. These findings support the potential utility of integrating inflammatory and coagulation biomarkers for early risk stratification. Moreover, they highlight the central role of the inflammation–coagulation axis in sepsis pathophysiology, with particular relevance for clinical practice in resource-limited settings.

About the authors

Agustin Iskandar

Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia

Email: Agustin_almi@ub.ac.id
ORCID iD: 0000-0001-9204-1958

Medical Doctor, Clinical Pathologist, PhD; Associate Profesor in the Medical Faculty Universitas Brawijaya, Indonesia;Department of Clinical Pathology, Faculty of Medicine Universitas Brawijaya/ Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia; Department of Clinical Pathology Study Programme, Faculty of Medicine Universitas Brawijaya/ Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia

Индонезия, Jaksa Agung Suprapto Street, 2, Malang, East Java, kode pos 65111.

Siti Fatonah

Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia

Email: titiksitifatonah@gmail.com

Medical Doctor, Clinical Pathologist; Lecturer in the Department of Clinical Pathology at Universitas Brawijaya in Malang, Indonesia; 

Department of Clinical Pathology, Faculty of Medicine Universitas Brawijaya/ Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia; 

Clinical Pathology Study Programme, Faculty of Medicine Universitas Brawijaya/ Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia.

Индонезия, Jaksa Agung Suprapto Street, 2, Malang, East Java, kode pos 65111.

Mira Soraya

Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia;
Ulin General Hospital, Banjarmasin, South Borneo, Indonesia

Email: mirasaqqaf@gmail.com

Medical Doctor, Clinical Pathologist; 

Clinical Pathology Study Programme, Faculty of Medicine Universitas Brawijaya/ Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia;

Department of Clinical Pathology, Ulin General Hospital, Banjarmasin, South Borneo, Indonesia.

Индонезия

Novi Nirwanti Lova

Indonesian Doctor Association, Malang, East Java, Indonesia

Author for correspondence.
Email: novilova92@gmail.com

Medical Doctor;

Indonesian Doctor Association, Malang, East Java, Indonesia.

Индонезия, Tangkuban Perahu street, 1B, Malang, East Java 65119

References

  1. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, Bozza MT, Castro-Faria-Neto HC, Bozza PT. Crit Care. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis.
  2. Crit Care, 2007; 11(2); R49 10.1186/cc5783
  3. Chen Z, Li C, Yu J. Front Med (Lausanne). Monocyte chemoattractant protein-1 as a potential marker for patients with sepsis: a systematic review and meta-analysis.
  4. Front Med (Lausanne) 2023, 1;10:1217784 https://pubmed.ncbi.nlm.nih.gov/37720514/
  5. Chousterman BG, Swirski FK, Weber GF. Semin Immunopathol. Cytokine storm and sepsis disease pathogenesis.
  6. Semin Immunopathol, 2017Jul; 39(5), 517-528 https://pubmed.ncbi.nlm.nih.gov/28555385/
  7. Deshmane SL, Kremlev S, Amini S, Sawaya BE. J Interferon Cytokine Res. Monocyte chemoattractant protein-1 (MCP-1): an overview.
  8. J Interferon Cytokine Res, 2009, 29 (6) : 313-326 https://pubmed.ncbi.nlm.nih.gov/19441883/
  9. Ding M, Li M, Yang H. Exp Ther Med. Clinical diagnostic value of combined detection of IMA, D-D and MCP-1 in acute myocardial infarction,
  10. Exp Ther Med, 2021; 21(5): 457 https://pubmed.ncbi.nlm.nih.gov/33747190/
  11. Duan Y, Liu M, Wang J, Wei B. Med Sci Monit. Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 (MCP-1) and 28-Day Mortality in Elderly Patients with Sepsis: A Retrospective Single-Center Study.
  12. Med Sci Monit, 2024; 30, e942079 https://pubmed.ncbi.nlm.nih.gov/38169464/
  13. Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, Mcintyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, Møller MH, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy M. Intensive Care Med. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.
  14. Intensive Care Med, 2021; 47(11): 1181-1247 https://pubmed.ncbi.nlm.nih.gov/34605781/
  15. Gao Q, Yang L, Teng F, Guo SB. BMC Emerg Med. Peripheral blood monocyte status is a predictor for judging occurrence and development on sepsis in older adult population: a case control study.
  16. BMC Emerg Med, 2023, 23(1): 11 https://pubmed.ncbi.nlm.nih.gov/36721090/
  17. Gotts JE, Matthay MA. BMJ. Sepsis: pathophysiology and clinical management.
  18. BMJ, 2016, 353, i1585 https://pubmed.ncbi.nlm.nih.gov/27217054/
  19. Han YQ, Yan L, Zhang L, Ouyang PH, Li P, Lippi G, Hu ZD. Biochem Med (Zagreb). Performance of D-dimer for predicting sepsis mortality in the intensive care unit.
  20. Biochem Med (Zagreb), 2021, 31(2): 020709 https://pubmed.ncbi.nlm.nih.gov/34140832/
  21. Iba T, Levy JH, Levi M, Connors JM, Thachil J. Crit Care Med. Coagulopathy of Coronavirus Disease 2019, Crit Care Med, 2020, 48, 9, 1358-1364 https://pubmed.ncbi.nlm.nih.gov/32467443/
  22. Iba T, Levy JH, Warkentin TE, Thachil J, van der Poll T, Levi M; Scientific and Standardization Committee on DIC, and the Scientific and Standardization Committee on Perioperative and Critical Care of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation.
  23. J Thromb Haemost, 2019, 17(11): 1989-1994 https://pubmed.ncbi.nlm.nih.gov/31410983/
  24. Innocenti F, Bianchi S, Guerrini E, Vicidomini S, Conti A, Zanobetti M, Pini R. Eur J Emerg Med. Prognostic scores for early stratification of septic patients admitted to an emergency department-high dependency unit.
  25. Eur J Emerg Med, 2014, 21(4): 254-9 https://pubmed.ncbi.nlm.nih.gov/23970100/
  26. Iskandar A, Prihastuti YA, Wulanda IA, Aprilia A, Anshory, Muhammad. Trends in Immunotherapy. Presepsin and Mortality Risk in Sepsis: A Valuable Tool for Predicting Patient Survival.
  27. Trends in Immunotherapy, 2025, 9 (2) : 107–117 https://ojs.ukscip.com/index.php/ti/article/view/1097
  28. Jansen MPB, Pulskens WP, Butter LM, Florquin S, Juffermans NP, Roelofs JJTH, Leemans JC. Shock. Mitochondrial DNA is Released in Urine of SIRS Patients With Acute Kidney Injury and Correlates With Severity of Renal Dysfunction. Shock. 2018; 49(3): 301-310 https://pubmed.ncbi.nlm.nih.gov/28837526/
  29. Jekarl DW, Kim JY, Ha JH, Lee S, Yoo J, Kim M, Kim Y. Dis Markers. Diagnosis and Prognosis of Sepsis Based on Use of Cytokines, Chemokines, and Growth Factors.
  30. Dis Markers, 2019, 8;2019:1089107 https://pubmed.ncbi.nlm.nih.gov/31583025/
  31. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M. Crit Care Med. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock, Crit Care Med, 2006, 34, 6, 1589-96 https://pubmed.ncbi.nlm.nih.gov/16625125/
  32. Liu VX, Fielding-Singh V, Greene JD, Baker JM, Iwashyna TJ, Bhattacharya J, Escobar GJ. Am J Respir Crit Care Med. The Timing of Early Antibiotics and Hospital Mortality in Sepsis, Am J Respir Crit Care Med, 2017, 196, 7, 856-863 https://pubmed.ncbi.nlm.nih.gov/28345952/
  33. Matsumoto H, Ogura H, Shimizu K, Ikeda M, Hirose T, Matsuura H, Kang S, Takahashi K, Tanaka T, Shimazu T. Sci Rep. The clinical importance of a cytokine network in the acute phase of sepsis, Sci Rep, 2018, 8, 1, 13995 https://pubmed.ncbi.nlm.nih.gov/30228372/
  34. Mikuła T, Sapuła M, Jabłońska J, Kozłowska J, Stańczak W, Krankowska D, Wiercińska-Drapało A. Mediators Inflamm. Significance of Heparin-Binding Protein and D-dimers in the Early Diagnosis of Spontaneous Bacterial Peritonitis, Mediators Inflamm, 2018, 2018, , 1969108 https://pubmed.ncbi.nlm.nih.gov/30363905/
  35. Rodelo JR, De la Rosa G, Valencia ML, Ospina S, Arango CM, Gómez CI, García A, Nuñez E, Jaimes FA. Am J Emerg Med. D-dimer is a significant prognostic factor in patients with suspected infection and sepsis, Am J Emerg Med, 2012, 30, 9, 1991-9 https://pubmed.ncbi.nlm.nih.gov/22795996/
  36. Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, Fleischmann-Struzek C, Machado FR, Reinhart KK, Rowan K, Seymour CW, Watson RS, West TE, Marinho F, Hay SI, Lozano R, Lopez AD, Angus DC, Murray CJL, Naghavi M. Lancet. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study
  37. Lancet, 2020, 395, 10219, 200-211 https://pubmed.ncbi.nlm.nih.gov/31954465/
  38. Schupp T, Weidner K, Rusnak J, Jawhar S, Forner J, Dulatahu F, Brück LM, Hoffmann U, Kittel M, Bertsch T, Akin I, Behnes M. Clin Lab. D-Dimer Levels and the Disseminated Intravascular Coagulation Score to Predict Severity and Outcomes in Sepsis or Septic Shock.Clin Lab, 2023, 69, 5, https://pubmed.ncbi.nlm.nih.gov/37145079/
  39. Schwameis M, Steiner MM, Schoergenhofer C, Lagler H, Buchtele N, Jilma-Stohlawetz P, Boehm T, Jilma B. Eur J Intern Med. D-dimer and histamine in early stage bacteremia: A prospective controlled cohort study.
  40. Eur J Intern Med, 2015, 26, 10, 782-6 https://pubmed.ncbi.nlm.nih.gov/26586287/
  41. Semeraro F, Ammollo CT, Caironi P, Masson S, Latini R, Panigada M, Pesenti A, Semeraro N, Gattinoni L, Colucci M. Blood Transfus. D-dimer corrected for thrombin and plasmin generation is a strong predictor of mortality in patients with sepsis.
  42. Blood Transfus, 2020, 18, 4, 304-311 https://pubmed.ncbi.nlm.nih.gov/31855152/
  43. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. JAMA. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3),
  44. JAMA, 2016, 315, 8, 801-10 https://pubmed.ncbi.nlm.nih.gov/26903338/
  45. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG. Intensive Care Med. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.
  46. Intensive Care Med, 1996, 22(7): 707-10 https://pubmed.ncbi.nlm.nih.gov/8844239/
  47. Yamamoto T, Kajikawa O, Martin TR, Sharar SR, Harlan JM, Winn RK. J Immunol. The role of leukocyte emigration and IL-8 on the development of lipopolysaccharide-induced lung injury in rabbits.
  48. J Immunol, 1998, 161(10): 5704-9 https://pubmed.ncbi.nlm.nih.gov/9820552/
  49. Yunus I, Fasih A, Wang Y. PLoS One. The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics,
  50. PLoS One, 2018, 13, 11, e0206527 https://pubmed.ncbi.nlm.nih.gov/30427887/
  51. Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, Zhang Z. J Thromb Haemost. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19,
  52. J Thromb Haemost, 2020, 18(6): 1324-1329 https://pubmed.ncbi.nlm.nih.gov/32306492/
  53. Zhu T, Liao X, Feng T, Wu Q, Zhang J, Cao X, Li H. Tohoku J Exp Med. Plasma Monocyte Chemoattractant Protein 1 as a Predictive Marker for Sepsis Prognosis: A Prospective Cohort Study。
  54. Tohoku J Exp Med, 2017, Volum 241, Issue 2, Pages 139-147 https://www.jstage.jst.go.jp/article/tjem/241/2/241_139/_article

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) Iskandar A., Fatonah S., Soraya M., Lova N.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies